Status:
COMPLETED
Effects of Fatty Acid Supplementation on Substance Dependent Individuals
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance-related Disorders
Eligibility:
All Genders
25-55 years
Phase:
PHASE2
Brief Summary
Many substance dependent individuals continue to abuse a variety of substances during treatment for their disorder. Often, substance dependent individuals are co-diagnosed with depression and violence...
Detailed Description
Past research suggests that low levels of some PUFAs play a role in the pathophysiology of depressive and aggressive disorders. In addition, there is also evidence that PUFAs play a role in treating s...
Eligibility Criteria
Inclusion
- Current or history of drug or alcohol dependence
- Used substances of abuse during the 3 months prior to study entry
- Enrolled in one of the VA New York Harbor Healthcare System Brooklyn campus substance abuse clinics
Exclusion
- Current or history of hallucinations, delusions, or memory problems
- Major physical illness (e.g., cardiovascular, pulmonary, gastrointestinal, renal, neuromuscular, or endocrine disorder)
- Liver function test greater than one standard deviation above upper normal limit
- Allergic to fish
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00312455
Start Date
July 1 2004
End Date
July 1 2005
Last Update
January 12 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.